Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ARTHEx Biotech logo — Developing microRNA modulators for diseases with unmet medic...

ARTHEx Biotech

Developing microRNA modulators for diseases with unmet medical needs

Founded 2019 Spain Spain 28 employees Series B Total: $62.95M Biotechnology

General Information

Company Name ARTHEx Biotech
Founded Year 2019
Location Spain Spain +2
Employees 28
Industries Biotechnology
Funding Stage Series B
Social

Get notified when ARTHEx Biotech moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ARTHEx Biotech

Analyzing ARTHEx Biotech, a spin-off biotech company from the University of Valencia, it is focused on developing microRNA modulators for diseases with unmet medical needs. The company has proprietary platform that enables efficient development of investigational miR-modulating oligonucleotides designed to enter relevant tissues in pharmacological quantities. Their first product, ATX-01, addresses Myotonic Dystrophy Type 1 (DM1), an orphan disease with no approved treatment. The €42.00M Series B investment at 03 May 2023 received from notable investors like CDTI, Columbus Venture Partners, and The European Innovation Council reflects confidence in the potential of ARTHEx Biotech's innovative approach. With unique mechanisms of action, the company is well-positioned to make a significant impact in the biotechnology industry and address unmet medical needs. For more information, visit www.arthexbiotech.com.

Taxonomy: Biotech, Biomedical research, Oligonucleotide therapies, MicroRNA modulation, Genetic diseases, Drug development, Neuromuscular diseases, Orphan disease treatments, Antisense RNA, Medical innovation, University spin-off, Pharmacological research, Clinical advisory, Rare diseases

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 7
Investor Investor Investor Investor
•••• •••• 		03 May 2023
Venture Round •••••• 1
Investor
25 Oct 2022
Grant •••••• 1
Investor
14 Oct 2022
Seed Round •••••• 2 •••• •••• 24 Jul 2020
Seed Round •••••• 1 •••• •••• 01 Jun 2020

View All 6 Funding Rounds

ARTHEx Biotech Alternatives & Competitors

ARTHEx Biotech vs
Apitope
Apitope Belgium

Develops drugs for treatments of allergic diseases

Series B
1 employees
Biotechnology, Health Care
Compare ARTHEx Biotech vs Apitope
ARTHEx Biotech vs
Araclon Biotech, S.L.
Araclon Biotech, S.L. Spain

La ciencia si no es honesta, no es ciencia. Dr. Manuel Sarasa.

Series Unknown
22 employees
Biopharma, Biotechnology
Compare ARTHEx Biotech vs Araclon Biotech, S.L.
ARTHEx Biotech vs
Visterra Inc.
Visterra Inc. United States

We bring better biologics to life. Biospace Best Place to Work 2024!

Series C
139 employees
Biotechnology, Health Care
Compare ARTHEx Biotech vs Visterra Inc.

FAQ About ARTHEx Biotech

Developing microRNA modulators for diseases with unmet medical needs
ARTHEx Biotech was founded in 2019.
ARTHEx Biotech is headquartered in Spain.
ARTHEx Biotech operates in the following industries: Biotechnology.
ARTHEx Biotech has approximately 28 employees.
ARTHEx Biotech has completed 6 funding rounds, raising a total of $62.95M. The latest funding stage is Series B.
Top alternatives and competitors to ARTHEx Biotech include Apitope, Araclon Biotech, S.L., Visterra Inc., Fountain Therapeutics, Neurotrope Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ARTHEx Biotech and Apitope are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ARTHEx Biotech and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy